FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1052217005: Maftivimab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4279083017 Maftivimab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4279084011 Maftivimab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Maftivimab Is a Monoclonal antibody true Inferred relationship Some
Maftivimab Is a Substance with antiviral mechanism of action (substance) true Inferred relationship Some
Maftivimab This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antiviral (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing atoltivimab and maftivimab and odesivimab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Maftivimab Inferred relationship Some 2
Product containing only atoltivimab and maftivimab and odesivimab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Maftivimab Inferred relationship Some 2
Atoltivimab- and maftivimab- and odesivimab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Maftivimab Inferred relationship Some 2
Atoltivimab and maftivimab and odesivimab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Maftivimab Inferred relationship Some 2

Reference Sets

GB English

US English

Back to Start